Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.
Combined antiplatelet and anticoagulant regimen aimed at dissolving persistent fibrin amyloid microclots suspected of contributing to Long COVID symptoms.
Information
Subcategory
Medication protocol
Evidence level
2/5
Evidence type
Uncontrolled reports and microclot hypothesis
Share your experience
Your feedback helps thousands of people find what really works.